The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study evaluating the safety and impact of pretreatment with metformin on colorectal cancer stem cells (CCSC) in patients undergoing resection.
Nicholas C. DeVito
No relevant relationships to disclose
Martin D. Goodman
No relevant relationships to disclose
Jennifer Caplain
No relevant relationships to disclose
Shrikar Rajagopal
No relevant relationships to disclose
Daniel Popowich
No relevant relationships to disclose
Bruce A Orkin
No relevant relationships to disclose
Elizabeth Grimm
No relevant relationships to disclose
Philip N. Tsichlis
No relevant relationships to disclose
Robert E. Martell
No relevant relationships to disclose
Wasif M. Saif
Consultant or Advisory Role - Novartis; Regeneron
Honoraria - Genentech; Novartis; Sanofi
Research Funding - Genentech; Gilead Sciences; Halozyme Therapeutics ; ImClone Systems; Merrimack Pharmaceuticals